BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Prognosis
11 results:

  • 1. Pathologic tumor response to neoadjuvant therapy in resected pancreatic cancer: does it affect prognosis?
    Donisi G; Nappo G; Pacilli M; Capretti GL; Spaggiari P; Sollai M; Bozzarelli S; Zerbi A
    Updates Surg; 2023 Sep; 75(6):1497-1508. PubMed ID: 37578734
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study.
    Wen C; Zhang L; Yang Y; Jin Y; Ren D; Zhang Z; Zou S; Li F; Sun H; Jin J; Lu X; Xie J; Cheng D; Xu Z; Chen H; Mao B; Zhang J; Wang J; Deng X; Peng C; Li H; Jiang C; Lin L; Zhang H; Chen H; Shen B; Zhan Q
    Int J Surg; 2023 Jul; 109(7):1941-1952. PubMed ID: 37026827
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study.
    Yang L; Su J; Wang W; Zhou F
    World J Surg Oncol; 2023 Jan; 21(1):19. PubMed ID: 36691032
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
    Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
    Lee SH; Yim SY; Jeong YS; Li QX; Kang SH; Sohn BH; Kumar SV; Shin JH; Choi YR; Shim JJ; Kim H; Kim JH; Kim S; Guo S; Johnson RL; Kaseb A; Kang KJ; Chun YS; Jang HJ; Lee BG; Woo HG; Ha MJ; Akbani R; Roberts LR; Wheeler DA; Lee JS
    Hepatology; 2022 Dec; 76(6):1634-1648. PubMed ID: 35349735
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort.
    Zhan Q; Wen C; Zhao Y; Fang L; Jin Y; Zhang Z; Zou S; Li F; Yang Y; Wu L; Jin J; Lu X; Xie J; Cheng D; Xu Z; Zhang J; Wang J; Deng X; Chen H; Peng C; Li H; Zhang H; Fang H; Wang C; Shen B
    EBioMedicine; 2021 Dec; 74():103716. PubMed ID: 34839264
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
    Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
    Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
    Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z
    Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens.
    Sonohara F; Yamada S; Takami H; Hayashi M; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Eur J Surg Oncol; 2019 Oct; 45(10):1895-1900. PubMed ID: 31147087
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.
    Sclafani F; Chau I; Cunningham D; Lampis A; Hahne JC; Ghidini M; Lote H; Zito D; Tabernero J; Glimelius B; Cervantes A; Begum R; De Castro DG; Wilson SH; Peckitt C; Eltahir Z; Wotherspoon A; Tait D; Brown G; Oates J; Braconi C; Valeri N
    Carcinogenesis; 2016 Sep; 37(9):852-7. PubMed ID: 27381831
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.